Viewing nowCombinationEmpagliflozin and Metformin Extended-Release Tablets 25/1000 mg
Metformin Hydrochloride 1000mg · Empagliflozin 25mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 202500993 · Approved 2025.04.24 · Insurance code 642707830
Improvement of glycemic control in adults with type 2 diabetes
This medication helps control blood sugar levels in adults with type 2 diabetes by combining Empagliflozin and Metformin. It is used alongside dietary and exercise regimens to effectively improve blood glucose levels. It is especially suitable for patients whose blood sugar control is inadequate, and extra care is needed in patients with cardiovascular diseases. This medication plays an important role in managing blood sugar control and cardiovascular health.
For antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and extended-release metformin hydrochloride 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily with the evening meal. To reduce gastrointestinal adverse reactions associated with metformin use, the dose of metformin hydrochloride should be increased gradually. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended initial total daily dose when taking this medicine is empagliflozin 10 mg and the patient's current dose of metformin. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg. Patients switching from combination therapy with empagliflozin and metformin to this medicine should receive their current doses of empagliflozin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When this medicine is coadministered with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. Because dose adjustment may be needed based on renal function, assessment of renal function is recommended before starting this medicine and periodically thereafter. No dose adjustment of this medicine is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2] who tolerate treatment well and have no other conditions that may increase the risk of lactic acidosis, this medicine may be used with adjustment of the metformin hydrochloride dose as follows. - The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If creatinine clearance (CrCl) decreases to less than 45 mL/min or estimated glomerular filtration rate (eGFR) decreases to less than 45 mL/min/1.73m2, discontinue this medicine immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used for the treatment of diabetes and works by combining two main ingredients to help control blood sugar levels. However, caution is necessary while taking this medication. Severe lactic acidosis, a rare side effect, may occur, which can be life-threatening, so any symptoms must be reported to healthcare professionals immediately. Also, when taken with insulin or other diabetes medications, hypoglycemia may occur, so blood sugar levels must be monitored carefully. Patients with poor kidney function or those suffering from acute infections, serious heart issues, or liver dysfunction should avoid using this medication. Particularly, this medication should be temporarily discontinued before and after surgeries or imaging exams requiring iodinated contrast, and it should only be resumed once kidney function is verified to be normal. This medication may increase the risk of genital and urinary tract infections, so immediate treatment is necessary if symptoms appear. Additionally, this medication can lower Vitamin B12 levels, so long-term users should check their Vitamin B12 status with blood tests. Alcohol consumption should be avoided during treatment, particularly in patients with liver or kidney problems or dehydration. Elderly patients or those with reduced kidney function may need to adjust their medication dosage and regularly monitor kidney function. This medication should not be broken, chewed, or crushed; it must be swallowed whole, and there is no need to worry if the tablet's coating is expelled intact in stool. Serious side effects can occur in case of overdose; hence, the medication should be taken precisely as directed by a physician, and any suspected side effects should be discussed with a healthcare provider immediately. Finally, it is crucial to have regular blood tests and consultations with healthcare providers to continuously monitor health conditions while taking this medication.
Severe lactic acidosis, hypoglycemia, urinary tract infection, genital infection, increased urination, decreased and deficiency of vitamin B12, ketoacidosis, lactic acidosis, decreased fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, altered taste, itching, rash, urticaria, erythema, angioedema, dysuria, interstitial nephritis, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, increased hematocrit, necrosis of the perineum, vulvovaginal candidiasis, vulvitis, glans inflammation, hypoglycemic episodes, decreased blood sugar, increased blood sugar, fluid volume loss, increased serum creatinine, decreased glomerular filtration rate, gastrointestinal symptoms (diarrhea, nausea, vomiting, indigestion, abdominal pain, loss of appetite), chronic gastritis, cerebral infarction, soft tissue infection, pneumonia, ankle fracture, epicondylitis, facial bone fracture, musculoskeletal pain, myocardial infarction, pancreatic adenocarcinoma, urinary sepsis, pyelonephritis, rash, urticaria, angioedema, necrosis of the perineum, constipation, gastritis, abdominal discomfort, anal incontinence, dry mouth, gastrointestinal disorder, gastroesophageal reflux disease, oral discomfort, salivary gland pain, headache, sensory impairment, postural dizziness, dizziness, amnesia, drowsiness, CNS-origin vertigo, facial paralysis, Parkinsonism, polyneuropathy, neuralgia, drowsiness, fatigue, peripheral edema, facial edema, peripheral swelling, fever, facial swelling, chills, strange sensation, edema, pain, pain at the puncture site, vascular stent stenosis, vascular stent thrombosis, chest pain, increased alanine aminotransferase, increased aspartate aminotransferase, weight gain, abnormal electrocardiogram, decreased hemoglobin, increased hemoglobin, positive Helicobacter test, positive urine red blood cells, ureteral calculi, acute kidney injury, chronic kidney disease, hematuria, overactive bladder, renal mass, urinary retention, urinary tract pain, urinary abnormalities, vulvar pruritus, benign prostatic hyperplasia, erectile dysfunction, atrophic vaginitis, cervical dysplasia, cervical inflammation, scrotal pain, sexual dysfunction, vaginal discharge, hypoglycemic episodes, decreased appetite, obesity, dyslipidemia, diabetes, hyperlipidemia, hyponatremia, dermal cyst, seborrheic dermatitis, atopic dermatitis, diabetic foot, nummular eczema, miliaria, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, arthralgia, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, musculoskeletal pain, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurred vision, corneal erosion, glaucoma, macular fibrosis, eye discomfort, conjunctival hyperemia, pathological myopia, retinal detachment, retinal crystals, retinal vein occlusion, traction retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, nasal bleeding, asthma, exertional dyspnea, wet cough, allergic rhinitis, residual phlegm, cough, skin laceration, contusion, rib fracture, concussion, corneal abrasion, falls, hand fracture, iliotibial band syndrome, open globe injury, pelvic fracture, road traffic accident, spleen injury, sternum fracture, angina pectoris, palpitations, Prinzmetal angina, coronary artery disease, tachycardia, atherosclerosis, deep vein thrombosis, diabetic vascular complications, peripheral arterial occlusive disease, anxiety, depression, sleep disturbances, acute cholecystitis, autoimmune hepatitis, cholelithiasis, hepatitis, otalgia, postural dizziness, dizziness, anemia, lymphadenopathy, hypothyroidism, thyroid mass, unstable angina
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air and moisture. It's essential to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the medication's efficacy and safety over time.
Pale yellow, double convex, oval-shaped extended-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 1000mg · Empagliflozin 25mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.